Table of Contents

1 Study Coverage

• 1.1 Gaucher Disease Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Gaucher Disease Market Size Growth Rate by Product
  • 1.4.2 Enzyme Replacement Therapy
  • 1.4.3 Substrate Reduction Therapy
• 1.5 Market by End User
  • 1.5.1 Global Gaucher Disease Market Size Growth Rate by End User
  • 1.5.2 Non-Neuronopathic Gaucher Disease
  • 1.5.3 Neuronopathic Gaucher Disease
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Gaucher Disease Market Size
  • 2.1.1 Global Gaucher Disease Revenue 2014-2025
  • 2.1.2 Global Gaucher Disease Sales 2014-2025
• 2.2 Gaucher Disease Growth Rate by Regions
  • 2.2.1 Global Gaucher Disease Sales by Regions
  • 2.2.2 Global Gaucher Disease Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Gaucher Disease Sales by Manufacturers
  • 3.1.1 Gaucher Disease Sales by Manufacturers
  • 3.1.2 Gaucher Disease Sales Market Share by Manufacturers
  • 3.1.3 Global Gaucher Disease Market Concentration Ratio (CR5 and HHI)
• 3.2 Gaucher Disease Revenue by Manufacturers
  • 3.2.1 Gaucher Disease Revenue by Manufacturers (2014-2019)
  • 3.2.2 Gaucher Disease Revenue Share by Manufacturers (2014-2019)
• 3.3 Gaucher Disease Price by Manufacturers
• 3.4 Gaucher Disease Manufacturing Base Distribution, Product Types
  • 3.4.1 Gaucher Disease Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Gaucher Disease Product Type
  • 3.4.3 Date of International Manufacturers Enter into Gaucher Disease Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Gaucher Disease Sales by Product
• 4.2 Global Gaucher Disease Revenue by Product
• 4.3 Gaucher Disease Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Gaucher Disease Breakdown Data by End User

6 North America

• 6.1 North America Gaucher Disease by Countries
  • 6.1.1 North America Gaucher Disease Sales by Countries
  • 6.1.2 North America Gaucher Disease Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Gaucher Disease by Product
• 6.3 North America Gaucher Disease by End User

7 Europe

• 7.1 Europe Gaucher Disease by Countries
  • 7.1.1 Europe Gaucher Disease Sales by Countries
  • 7.1.2 Europe Gaucher Disease Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Gaucher Disease by Product
• 7.3 Europe Gaucher Disease by End User

8 Asia Pacific

• 8.1 Asia Pacific Gaucher Disease by Countries
  • 8.1.1 Asia Pacific Gaucher Disease Sales by Countries
  • 8.1.2 Asia Pacific Gaucher Disease Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Gaucher Disease by Product
• 8.3 Asia Pacific Gaucher Disease by End User

9 Central & South America

• 9.1 Central & South America Gaucher Disease by Countries
  • 9.1.1 Central & South America Gaucher Disease Sales by Countries
  • 9.1.2 Central & South America Gaucher Disease Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Gaucher Disease by Product
• 9.3 Central & South America Gaucher Disease by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Gaucher Disease by Countries
  • 10.1.1 Middle East and Africa Gaucher Disease Sales by Countries
  • 10.1.2 Middle East and Africa Gaucher Disease Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Gaucher Disease by Product
• 10.3 Middle East and Africa Gaucher Disease by End User

11 Company Profiles

• 11.1 Sanofi
  • 11.1.1 Sanofi Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Sanofi Gaucher Disease Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Sanofi Gaucher Disease Products Offered
  • 11.1.5 Sanofi Recent Development
• 11.2 Shire
  • 11.2.1 Shire Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Shire Gaucher Disease Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Shire Gaucher Disease Products Offered
  • 11.2.5 Shire Recent Development
• 11.3 Actelion Pharma
  • 11.3.1 Actelion Pharma Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Actelion Pharma Gaucher Disease Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Actelion Pharma Gaucher Disease Products Offered
  • 11.3.5 Actelion Pharma Recent Development
• 11.4 Pfizer
  • 11.4.1 Pfizer Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Pfizer Gaucher Disease Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Pfizer Gaucher Disease Products Offered
  • 11.4.5 Pfizer Recent Development
• 11.5 ISU Pharm
  • 11.5.1 ISU Pharm Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 ISU Pharm Gaucher Disease Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 ISU Pharm Gaucher Disease Products Offered
  • 11.5.5 ISU Pharm Recent Development

12 Future Forecast

• 12.1 Gaucher Disease Market Forecast by Regions
  • 12.1.1 Global Gaucher Disease Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Gaucher Disease Revenue Forecast by Regions 2019-2025
• 12.2 Gaucher Disease Market Forecast by Product
  • 12.2.1 Global Gaucher Disease Sales Forecast by Product 2019-2025
  • 12.2.2 Global Gaucher Disease Revenue Forecast by Product 2019-2025
• 12.3 Gaucher Disease Market Forecast by End User
• 12.4 North America Gaucher Disease Forecast
• 12.5 Europe Gaucher Disease Forecast
• 12.6 Asia Pacific Gaucher Disease Forecast
• 12.7 Central & South America Gaucher Disease Forecast
• 12.8 Middle East and Africa Gaucher Disease Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Gaucher Disease Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Gaucher Disease market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Gaucher Disease market based on company, product type, end user and key regions.

This report studies the global market size of Gaucher Disease in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gaucher Disease in these regions.
This research report categorizes the global Gaucher Disease market by top players/brands, region, type and end user. This report also studies the global Gaucher Disease market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
Shire
Actelion Pharma
Pfizer
ISU Pharm

Market size by Product
Enzyme Replacement Therapy
Substrate Reduction Therapy
Market size by End User
Non-Neuronopathic Gaucher Disease
Neuronopathic Gaucher Disease

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Gaucher Disease market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Gaucher Disease market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Gaucher Disease companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Gaucher Disease submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Gaucher Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gaucher Disease market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.